Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcoma.

Abstract

Endometrial stromal sarcoma (ESS) accounts for approximately 20% of all uterine sarcomas and presents, at a mean age, around 50 years of age. Half of the patients are premenopausal. ESS often manifests as an endometrial polyp and 60% of cases present with FIGO stage I disease. The natural history is one of slow growing indolent disease. Typical microscopic… (More)
DOI: 10.1097/IGC.0000000000000205

Topics

2 Figures and Tables

Cite this paper

@article{Amant2014GynecologicCI, title={Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcoma.}, author={Fr{\'e}d{\'e}ric Amant and Anne Floquet and Michael Friedlander and Gunnar Balle Kristensen and Sven Mahner and Eun Ji Nam and Matthew A. Powell and I Ray-coquard and N. Siddiqui and Peter Sykes and Anneke M. Westermann and Beatrice M. Seddon}, journal={International journal of gynecological cancer : official journal of the International Gynecological Cancer Society}, year={2014}, volume={24 9 Suppl 3}, pages={S67-72} }